Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
T cell receptor delta diversity 1 (TRDD1) is a gene segment that encodes one of the two diversity (D) gene segments within the T cell receptor delta (TRD) locus in humans[1][5]. It is not a protein, enzyme, receptor, or drug target itself, but rather a genomic sequence that contributes to the diversity of the T cell receptor delta chain by participating in V(D)J recombination during T cell development[1][3][4]. These D segments are used as part of the rearrangement process that creates a highly variable antigen recognition domain of the γδ T cell receptor, crucial for immune recognition performed by γδ T cells. Unlike functional receptor proteins, TRDD1 is not itself a therapeutic target, biomarker, or druggable entity, but plays a fundamental role in the genetic mechanisms that generate immune diversity[1][3][5]. ### Key points for structuring: - **TRDD1 is not a receptor or protein**, but a DNA segment; therefore, it is not considered a direct therapeutic target. - The **entry is potentially incorrect if interpreted as a molecular drug target or therapeutic protein**, but technically correct as a gene segment contributing to antigen receptor diversity[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T cell receptor delta diversity 1 (TRDD1).